# DESCRIPTION

## FIELD OF INVENTION

- introduce immunogenic conjugate molecules

## BACKGROUND OF THE INVENTION

- describe persistent infections and biofilm formation

## OBJECT OF THE INVENTION

- provide immunogenic AHL protein

## SUMMARY OF THE INVENTION

- develop immunogenic AHL conjugate vaccine

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

### Methods and Results

- express and purify KatA protein
- conjugate OdDHL to KatA protein
- analyze and characterize conjugate

### Mouse and Inoculation Schedule

- immunize mice with KatA-OdDHL conjugate

### Human Immunity

- test human plasma for antibodies to OdDHL

### Variations

- describe modifications and variations of the invention

